About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
-Advanced
-Search Guidelines
Home
Advanced Search
Go to Top
Go to Top
Go to Bottom
Go to Bottom
8 results
1 of 1
1
Lung Related Complications in Patients with Advanced Thyroid Cancer during Lenvatinib Therapy: Case Series and Literature Review
Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Int J Thyroidol.
2022;15(1):42-48. Published online 2022 May 30 DOI:
http://dx.doi.org/10.11106/ijt.2022.15.1.42
2
Treatment Effect of Combining Lenvatinib and Vemurafenib for
BRAF
Mutated Anaplastic Thyroid Cancer
Chae Moon Hong, Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Byeong-Cheol Ahn
Int J Thyroidol.
2021;14(2):127-134. Published online 2021 November 30 DOI:
http://dx.doi.org/10.11106/ijt.2021.14.2.127
3
A case report of a patient presented with skin ulcer after treatment of lenvatinib
Serin Cha, Dong Woo Kim, Jung Wan Choe, Tae Hyung Kim, Seung Young Kim, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Young Kul Jung, Hyung Joon Yim
J Liver Cancer.
2021;21(2):194-198. Published online 2021 September 30 DOI:
http://dx.doi.org/10.17998/jlc.2021.09.20
4
Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma
Pil Soo Sung, Sung Woo Cho, Jaejun Lee, Hyun Yang, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
J Liver Cancer.
2020;20(2):128-134. Published online 2020 September 30 DOI:
http://dx.doi.org/10.17998/jlc.20.2.128
5
Successful Treatment of Cavernous Sinus Metastasis from Follicular Thyroid Carcinoma with Lenvatinib
Tee Sin Lee, Anna See, Caleb Lim, Xin Yong Huang
Int J Thyroidol.
2020;13(1):60-63. Published online 2020 May 30 DOI:
http://dx.doi.org/10.11106/ijt.2020.13.1.60
6
A Case of Severe Pneumocystis Pneumonia in a Thyroid Cancer Patient Receiving Lenvatinib
Mei Hua Jin, Won Gu Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon
Int J Thyroidol.
2019;12(2):127-131. Published online 2019 November 30 DOI:
http://dx.doi.org/10.11106/ijt.2019.12.2.127
7
Adverse Events of Tyrosine Kinase Inhibitors in Patients with Advanced Thyroid Cancer
Min Joo Kim, Young Joo Park
Int J Thyroidol.
2018;11(2):61-70. Published online 2018 November 30 DOI:
http://dx.doi.org/10.11106/ijt.2018.11.2.61
8
Management of Hypertension and Proteinuria after Treatment with Lenvatinib for Radioiodine Refractory Papillary Thyroid Carcinoma: a Case Report
Eyun Song, Won Gu Kim
Int J Thyroidol.
2018;11(2):78-81. Published online 2018 November 30 DOI:
http://dx.doi.org/10.11106/ijt.2018.11.2.78
1 of 1